RICHMOND, BRITISH COLUMBIA--(Marketwire - April 15, 2008) - MEDICAL VENTURES CORP. (TSX VENTURE:MEV), a medical devices company specializing in products for the vascular and surgical markets, provides the following progress update on its pre-market approval (PMA) application for the Metricath Gemini® dual-balloon angioplasty catheter:- The Company received an interim response to its PMA application from the U.S. Food & Drug Administration. The response requests additional information related to clinical and non-clinical aspects of the application that was submitted in Q4 2007. Medical Ventures is assembling the requested information with the assistance of the investigational sites that participated in the GAAME (Gemini Angioplasty and Arterial Measurement Evaluation) clinical trial and is targeting to submit this information to the FDA in June.
full article >> http://www.marketwire.com/mw/release.do?id=843829
No comments:
Post a Comment